BioGaia Sales Rise in Q3

Operating profit was SEK 8.6 million (6.4), an improvement of SEK 2.2 million (34%). Excluding foreign exchange effects and early deliveries in the second quarter 2009, operating income rose by 13%.

Oct 28 2010 --- BioGaia has reported that net sales in Q3 amounted to SEK 48.9 million (38.7) (EUR5.25 million),, an increase of SEK 10.2 million (26%). Excluding foreign exchange effects and the effect of early deliveries in the second quarter 2009, the increase in net sales was 20%.

Operating profit was SEK 8.6 million (6.4), an improvement of SEK 2.2 million (34%). Excluding foreign exchange effects and early deliveries in the second quarter 2009, operating income rose by 13%.

Profit before tax was SEK 12.9 million (11.3), an increase of SEK 1.6 million (14%).

Profit after tax was SEK 8.0 million (7.7), an improvement of SEK 0.3 million (4%).

Key events in the third quarter of 2010:

Study showing that Lactobacillus reuteri Protectis is effective in infants with chronic constipation published in Journal of Pediatrics.

Collaboration agreement with SCA regarding intimate hygiene products and products for the elderly.

"..Nestlé has started its launch in 19 countries and took sizeable deliveries of cultures for infant formula with Reuteri. Nestlé is thus on its way to becoming one of our largest customers. In other respects we have seen a continuation of the trend noted earlier in the year, namely that sales of probiotic drops and tablets in Europe are very strong, whereas sales in Japan have not yet gained momentum after the change in our business model there" says Peter Rothschild, President of BioGaia.